« Zurück
Home /
Epiberberine (chloride)

Epiberberine (chloride)

ArtNr	HY-N0226A-5mg
Hersteller	MedChem Express
CAS-Nr.	889665-86-5
Menge	5 mg
Quantity options	10mM/1mL 10 mg 50 mg 5 mg
Kategorie	Neuroscience Metabolism Cholesterol & Lipid Metabolism Molecular Targets for Neuroscience Aging & Neurological Disorders Neural Signaling Protein Aggregation, Clearance & Misfolding Enzymes Other Fatty Acid Enzymes Inhibitors & Compound Libraries Small Molecules
Typ	Inhibitors
Specific against	other
Purity	99.02
Formula	C20H18ClNO4
Citations	Molecules. 2024 May 14.<br/>Aging (Albany NY). 2021 Oct 9;13(19):23193-23209.<br/>J Biomol Struct Dyn. 2022 Dec 29;1-38.<br/>J Ethnopharmacol. 2024 Feb 19:117931.<br/>[1]Jung HA, et al. Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol Pharm Bull. 2009 Aug;32(8):1433-8.<br/>[2]Choi JS, et al. Anti-adipogenic effect of epiberberine is mediated by regulation of the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways. Arch Pharm Res. 2015 Dec;38(12):2153-62.<br/>[3]Ma H, et al. Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice. Drug Dev Res. 2016 Jun;77(4):163-70.
Smiles	COC1=C(OC)C=C2C(CC[N+]3=C2C=C(C=C4)C(C5=C4OCO5)=C3)=C1.[Cl-]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	889665-86-5
Lieferbar
Product Description	Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor, with IC50s of 1.07, 6.03 and 8.55 μM, respectively. Epiberberine chloride has antioxidant activity, with peroxynitrite ONOO- scavenging effect (IC50, 16.83 μM), and may protect against Alzheimer disease[1]. Epiberberine chloride inhibits the early stage of differentiation of 3T3-L1 preadipocytes, downregulates the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways[2]. Epiberberine has the potential effect in the research of diabetic disease[3].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	371.81
Clinical Information	No Development Reported
Manufacturers Research Area	Metabolic Disease; Neurological Disease
Solubility	DMSO : 25 mg/mL (ultrasonic)
Target	Beta-secretase; Cholinesterase (ChE); Reactive Oxygen Species
Manufacturers Target	Beta-secretase; Cholinesterase (ChE); Reactive Oxygen Species
Isoform	AChE; BACE1; BChE
Manufacturers Pathway	Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Manufacturers Product type	Natural Products

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkdatenblatt anfordern

HY-N0226A-5mg-safety-datasheet.pdf